No given over guidelines Q2R1 but british documentry say minimum 10 present required
Category: hold time study
how can Hold Time study in pharma industry ?
Pharmaceutical drug products stability Follow the guidelines are mentioned in ICH, FDA, EMEA and WHO guidelines.
If any inconsistency results observed then another two lots can be used for this study. Although there are no specific regulations or guidance documents on bulk product hold times, GMP dictates that hold times should be validated to ensure that in-process and bulk product can be held, pending the next processing step, without any adverse effect to the quality of the material. Hold time study provides the re-assurance of the quality at each in-process stages.
Hold Time Stability Study
Hold stability study can demonstrates how much time is suitable for hold the blend or bulk stage before processing to the next stage.
Hold time stability results meet the product specifications. Hold time study shall be carried out with the storage container packing’s only. If the dosage form is stored in bulk containers for over 30 days, real-time stability data under specified conditions should be generated to demonstrate comparable stability to the dosage form in the marketed package
Hold Time Stability Study Flow
Hold time studies use scale up commercial validation stages. Before scale up review flow of hold study has represented in In the pharmaceutical industry
- Selection of critical steps
- Hold study time points and tests;
- Hold study protocol;
- Hold study analysis;
- Hold study report .
- Hold study results evaluation.
- Hold Study Time day of calculated